SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending due to a surprise $1.5 billion share offering, sparking dilution fears despite strong Q3 results and a 92% YTD gain; the community is debating the offering's implications, with some viewing it as a strategic move for future growth and potential S&P 500 inclusion, while others express concerns about shareholder value and management's intentions.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a massive short squeeze, with community members citing a high short interest and low float as primary drivers. Chatter suggests retail investors are coordinating to hold the stock, aiming for astronomical price targets and drawing comparisons to previous short squeeze events like HKD. Some users are also attributing the surge to the company's technology and potential partnerships in the precious metals industry.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors speculate on upcoming news, particularly around potential hyperscaler partnerships and the sale of their cloud services unit, which could accelerate growth; community chatter highlights the company's strong position in AI infrastructure and data centers, drawing comparisons to early-stage SMCI due to its focus on AI compute demand. Some traders anticipate a short squeeze and are closely watching for news that could drive the stock higher, while others caution against hype and emphasize the importance of solid execution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to the announcement of a $150M public offering, leading to discussions about dilution and its potential impact on the stock's short-term momentum. Despite dilution concerns, some investors view the offering as a positive move that strengthens the company's cash position and supports long-term growth, especially regarding expansion of their exosome platform. The community is debating whether this offering is a strategic move or a setback, with some anticipating a short squeeze and others predicting a price decline.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies (QCLS) is trending due to investor Martin Shkreli taking a position in the company and setting a bold price target, sparking discussions of a potential short squeeze. The community is actively discussing the stock's potential in the photonics sector, with comparisons being made to recent high-flying stocks. Bullish sentiment is growing as traders anticipate continued upward momentum.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending as the community discusses the company's potential, particularly regarding a possible short squeeze and upcoming BFS report. Conversations revolve around the significance of Greenland's resources, potential government support, and the strategic importance of critical minerals, driving speculative interest. Community members are weighing bullish prospects against concerns about the company's management and past performance.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid renewed discussions around deep-sea mining and critical mineral supply chains, potentially fueled by government interest and upcoming events in Washington D.C. Community members are actively debating the stock's potential catalysts, likelihood of regulatory approvals and its valuation compared to other mining companies. Bullish sentiment is building with some anticipating a squeeze on short positions.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid speculation of a potential acquisition of Warner Bros. Discovery, with discussions focused on securing content and reshaping the streaming landscape. The community is weighing the potential benefits against regulatory hurdles and debt concerns that could impact the stock's value. Some traders anticipate a short squeeze, while others believe a deal could signal a peak for NFLX.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics is trending due to significant price movement and high volume, sparking discussions about potential short squeezes and comparisons to other high-flying stocks like $SMX. The community is actively debating entry and exit points, with some expressing bullish sentiment and anticipating further gains, while others caution about potential pullbacks. Overall, speculation and excitement around quick profits appear to be driving the conversation.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid speculation around ongoing bidding, with community chatter focusing on Netflix as a potential frontrunner and regulatory hurdles the deal may face. Community members are debating the merits of different offers and the potential impact on shareholders. Discussions also involve potential bidding wars and the influence of political factors on the outcome.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ITCI $JNJ $NBIX $XBI The whole sector’s M&amp;A multiple has come down significantly. No one is willing to pay that high premium as the DCF discount rate has spiked.

Idvst8

JulioD

Carolyn P Brown

Blaze Turner

$NBIX trades for a market cap of $10B at $100/share. NBIX is profitable &amp; has $2B in cash so its enterprise value is just over $8B. 
 
By comparison, $ITCI was acquired by $JNJ for an enterprise value of $13.6B. 
 
NBIX generated 4X more in product sales than ITCI in FY23 &amp; FY24 and at higher gross margins. NBIX is expected to generate 1.3X more in revenues between FY25 &amp; FY34 than ITCI. 
 
If NBIX was acquired at the same multiple of cumulative 10-year projected sales as ITCI, this would be an enterprise of roughly $18B &amp; a market cap of roughly $20B (double where NBIX trades today). Because NBIX generates a higher gross margin than ITCI, it could be argued NBIX warrants a higher multiple. 
 
The attached graph compares actual FY23 &amp; FY24 NBIX revenues v ITCI as well as 10 year projected revenues. $XBI  
 
This is not investment advice. For all we know, NBIXC projected revenues are inaccurate.

StockTwits Web

Neurocrine Biosciences, Inc.

Intra-Cellular Therapies Inc

Johnson & Johnson

SPDR S&P Biotech ETF

Night Owl Biotech Research

StockTwits for iOS

 The whole sector’s M&A multiple has come down significantly. No one is willing to pay that high premium as the DCF discount rate has spiked.